Global Clinical Trial Management Systems (CTMS) Market 2022 - Snapshot
In 2021, the global CTMS market stood at USD 944 million. Recording a CAGR of 11.6% from 2022 to 2028, the worth is projected to reach ~USD 2,035 million by 2028, according to a new report by Gen Consulting Company.
This industry report offers market estimates of the global market, followed by a detailed analysis of the product, deployment mode, delivery mode, and region. The global market data on CTMS can be segmented by product: services, software. According to the research, the software segment had the largest share in the global CTMS market. CTMS market is further segmented by deployment mode: enterprise-based CTMS, site-based CTMS. In 2021, the enterprise-based CTMS segment made up the largest share of revenue generated by the CTMS market. Based on delivery mode, the CTMS market is segmented into: cloud-based, on-premise, web-based. Among these, the web-based segment was accounted for the highest revenue generator in 2021. On the basis of region, the CTMS market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). North America captured the largest share of the market in 2021.
The global CTMS market is highly competitive. Some of the leading companies operating in the market are Advarra Inc., ArisGlobal LLC, Clario (Bioclinica), DataTrak International Inc., IBM Corporation, Medidata Solutions Inc., Oracle Corporation, Paraxel International Corporation, Veeva Systems Inc.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook